Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

24.64
+0.02500.10%
Volume:12.97M
Turnover:319.20M
Market Cap:140.06B
PE:17.81
High:24.68
Open:24.52
Low:24.48
Close:24.61
Loading ...

BRIEF-Xtandi® Plus Leuprolide Significantly Improves Survival Outcomes In Men With Non-Metastatic Hormone-Sensitive Prostate Cancer With High-Risk Biochemical Recurrence

Reuters
·
10 Jul

Pfizer Announces Positive Results from Phase 3 EMBARK Study on XTANDI® for Non-Metastatic Hormone-Sensitive Prostate Cancer

Reuters
·
10 Jul

Xtandi® Plus Leuprolide Significantly Improves Survival Outcomes in Men With Non-Metastatic Hormone-Sensitive Prostate Cancer With High-Risk Biochemical Recurrence

THOMSON REUTERS
·
10 Jul

Pfizer Inc - Xtandi Plus Leuprolide Improves Overall Survival

THOMSON REUTERS
·
10 Jul

Pfizer: No New Safety Signals Were Observed in Analysis, and Safety Results Were Consistent With Demonstrated Safety Profile of Xtandi

THOMSON REUTERS
·
10 Jul

Pfizer: Embark Met Key Secondary Endpoint

THOMSON REUTERS
·
10 Jul

Singapore to Discuss Pharmaceutical Supply Chain Issues With US

Bloomberg
·
10 Jul

Pfizer’s Inclacumab Study: A Promising Step for Sickle Cell Disease Treatment

TIPRANKS
·
10 Jul

Pfizer’s ATGAM Study: A Key Update for Investors

TIPRANKS
·
10 Jul

Pfizer’s Gene Therapy Study for Duchenne Muscular Dystrophy: A Promising Update

TIPRANKS
·
10 Jul

Pantera Minerals Sells Smackover Lithium Project for A$40 Million

TIPRANKS
·
09 Jul

Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
09 Jul

Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs

MT Newswires Live
·
09 Jul

Pfizer’s Abrocitinib Study: A Potential Game-Changer for Atopic Dermatitis Treatment

TIPRANKS
·
09 Jul

Pfizer’s CIBINQO Pregnancy Study: Safety Insights for Investors

TIPRANKS
·
09 Jul

Pfizer’s Zavicefta Study: Ensuring Safety and Effectiveness in Korea

TIPRANKS
·
09 Jul

Pfizer’s Abrysvo Study: Ensuring Vaccine Safety for Older Adults

TIPRANKS
·
09 Jul

Pfizer and Astellas Pharma’s Promising Prostate Cancer Study: A Market Game-Changer?

TIPRANKS
·
09 Jul

Pfizer’s Promising Phase 3 Study on Rimegepant for Menstrual Migraine Prevention

TIPRANKS
·
09 Jul

US Pharma Stocks Rally. Moderna up 11%; Novavax up 7%; Regeneron Pharma up 3%

Tiger Newspress
·
08 Jul